Undiagnosed Diseases Overwhelm NIH

An NIH program to identify mystery diseases has stopped accepting applications after being flooded with cases.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Clinical Research CenterNATIONAL INSTITUTE OF HEALTH

A National Institutes of Health program to diagnose rare diseases is, for now, no longer accepting new applications. After receiving more than 5400 queries and 1900 applications since its inception in 2008, the Undiagnosed Diseases Program, which aims to gain basic knowledge of rare human diseases and to aid those suffering from them, decided to take a break from new applications to eliminate the backlog of cases it has already taken on.

Reviewers selected 450 applicants, whose medical records provided promising leads, and NIH investigators have looked into 350 of those cases so far. Selected patients come to the NIH’s Bethesda, Maryland, clinic for a complete medical workup by NIH staff, including genome sequencing. Earlier this year, the program published its first findings, identifying in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tia Ghose

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo